Author:
Kurz A.,Farlow M.,Lefèvre G.
Reference20 articles.
1. Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer’s disease;Cutler;Acta Neurol Scand,1998
2. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer’s disease;Imbimbo;CNS Drugs,2001
3. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease;Corey-Bloom;Int J Geriatr Psychopharmacol,1998
4. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial;Rösler;BMJ,1999
5. Systematic review of the efficacy of rivastigmine for patients with Alzheimer’s disease;Schneider;Int J Geriatr Psychopharmacol,1998
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献